Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 3
1993 2
1995 2
1996 3
1997 1
1998 2
1999 2
2001 2
2002 1
2005 1
2015 1
2016 3
2017 5
2018 6
2019 7
2020 6
2021 19
2022 7
2023 9
2024 7
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Drug-induced Liver Injury in Latin America: 10-year Experience of the Latin American DILI (LATINDILI) Network.
Bessone F, Hernandez N, Medina-Caliz I, García-Cortés M, Schinoni MI, Mendizabal M, Chiodi D, Nunes V, Ridruejo E, Pazos X, Santos G, Fassio E, Parana R, Reggiardo V, Tanno H, Sanchez A, Tanno F, Montes P, Tagle M, Arrese M, Brahm J, Girala M, Lizarzabal MI, Carrera E, Zerega A, Bianchi C, Reyes L, Arnedillo D, Cordone A, Gualano G, Jaureguizahar F, Rifrani G, Robles-Díaz M, Ortega-Alonso A, Pinazo-Bandera JM, Stephens C, Sanabria-Cabrera J, Bonilla-Toyos E, Niu H, Alvarez-Alvarez I, Lucena MI, Andrade RJ. Bessone F, et al. Among authors: alvarez alvarez i. Clin Gastroenterol Hepatol. 2025 Jan;23(1):89-102. doi: 10.1016/j.cgh.2024.06.030. Epub 2024 Jul 9. Clin Gastroenterol Hepatol. 2025. PMID: 38992407
Control compounds for preclinical drug-induced liver injury assessment: Consensus-driven systematic review by the ProEuroDILI network.
Segovia-Zafra A, Villanueva-Paz M, Serras AS, Matilla-Cabello G, Bodoque-García A, Di Zeo-Sánchez DE, Niu H, Álvarez-Álvarez I, Sanz-Villanueva L, Godec S, Milisav I, Bagnaninchi P, Andrade RJ, Lucena MI, Fernández-Checa JC, Cubero FJ, Miranda JP, Nelson LJ. Segovia-Zafra A, et al. Among authors: alvarez alvarez i. J Hepatol. 2024 Oct;81(4):630-640. doi: 10.1016/j.jhep.2024.04.026. Epub 2024 May 3. J Hepatol. 2024. PMID: 38703829 Free article.
Intestinal permeability and immune-inflammatory markers in patients with idiosyncratic drug-induced liver injury, drug-induced steatosis and metabolic dysfunction-associated steatotic liver disease (MASLD).
Di Zeo-Sánchez DE, Díaz-Alberola I, Pinazo-Bandera JM, García-Cortés M, Sanabria-Cabrera J, Robles-Díaz M, Álvarez-Álvarez I, Lucena MI, Andrade RJ, Villanueva-Paz M, Stephens C. Di Zeo-Sánchez DE, et al. Among authors: alvarez alvarez i. Br J Pharmacol. 2025 Nov;182(21):5303-5316. doi: 10.1111/bph.70123. Epub 2025 Jun 25. Br J Pharmacol. 2025. PMID: 40562415
Epigenetic modifications in drug-induced liver injury: A systematic review.
de Los Santos-Fernández RL, Segovia-Zafra A, Paz-López G, Matilla-Cabello G, Niu H, Álvarez-Álvarez I, Stephens C, González-Jiménez A, Lucena MI, Andrade RJ, Medina-Cáliz I. de Los Santos-Fernández RL, et al. Among authors: alvarez alvarez i. Br J Clin Pharmacol. 2025 Jun;91(6):1660-1674. doi: 10.1002/bcp.70053. Epub 2025 Mar 25. Br J Clin Pharmacol. 2025. PMID: 40134104
Epigenetic modifications in drug-induced liver injury: A systematic review.
de Los Santos-Fernández RL, Segovia-Zafra A, Paz-López G, Matilla-Cabello G, Niu H, Álvarez-Álvarez I, Stephens C, González-Jiménez A, Lucena MI, Andrade RJ, Medina-Cáliz I. de Los Santos-Fernández RL, et al. Among authors: alvarez alvarez i. Br J Clin Pharmacol. 2025 Jun;91(6):1660-1674. doi: 10.1111/bcp.70053. Br J Clin Pharmacol. 2025. PMID: 40441699
77 results